Abstract:Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time. Learn More Submit Now Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here. Loading metrics Open Access Correction In Fig 3B, the Liver 1 and Liver 2 panels for FK506 were erroneously duplicated. The Liver 1 image is correct. An updated version of Fig 3 is provided here in which the Liver 2 FK506 panel has been replaced. Underlying quantification data supporting Fig 3C from recent replicate analyses of the samples used in the original experiments are available in S2, S3, S4 and S5 Files. The original individual-level quantitative data from which Fig 3C were generated are no longer available. In the ACT panel of Fig 5A, the bands in lane 16 (labelled as animal 4 of the CON group) were repositioned lower to align with the other lanes to correct for a slow gel migration artifact. An updated Fig 5A is provided here in which the ACT panel is shown without selective adjustment of lane 16. The original underlying gel for Fig 5A is provided in S1 File. Underlying data for Figs 3A, 4A, and 7A are also provided here in S1 File. The remaining data for this article are available upon request from the corresponding author as per the data availability policy in place at the time of the article's publication. The PLOS ONE Editors apologize for the delay in resolving this matter. The authors apologize for the errors in the published article. A. Masson's trichrome staining of the liver sections from rats treated for 4 weeks as indicated. Two livers of each treatment group are shown at 100× magnification. B. 500× magnification of the squared sections in A. C. Percentage of liver fibrosis was determined from the Masson's trichrome staining using ImageJ software and plotted as percent fibrotic area vs. total liver area. Data represents average and±1 SEM from 8 rats, *** represents significance at p<0.01. D. and E. Aminotransferases in plasma of the experimental animals. The activity is presented as average and±1 SEM of 8 animals analyzed in duplicate. https://doi.org/10.1371/journal.pone.0306020.g001 A. Total RNA from the livers of treated animals was analyzed by RT-PCR for expression of lipopolysaccharide binding protein mRNA (LPS-BP) and CD64 mRNA. Data from 4 animals of each group are shown. Loading control, actin (ACT). B. Quantification of expression of LPS-BP mRNA after normalization to actin mRNA expression. The data from all 8 animals were used and presented as average and±1 SEM. * represents significance at p<0.05. C. Quantification of expression of CD64 mRNA after normalization to actin mRNA. *** represents significance at p<0.01 and * represents significance at p<0.05. https://doi.org/10.1371/journal.pone.0306020.g002 . https://doi.org/10.1371/journal.pone.0306020.s001 (PDF) https://doi.org/10.1371/journal.pone.0306020.s002 (ZIP) https://doi.org/10.1371/journal.pone.0306020.s003 (ZIP) https://doi.org/10.1371/journal.pone.0306020.s004 (ZIP) . https://doi.org/10.1371/journal.pone.0306020.s005 (ZIP) Citation: Manojlovic Z, Blackmon J, Stefanovic B (2024) Correction: Tacrolimus (FK506) Prevents Early Stages of Ethanol Induced Hepatic Fibrosis by Targeting LARP6 Dependent Mechanism of Collagen Synthesis. PLoS ONE 19(6): e0306020. https://doi.org/10.1371/journal.pone.0306020 Published: June 20, 2024 Copyright: © 2024 Manojlovic et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US

Corrections to Discovery of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, a Readily Available and Orally Active Glitazone for the Treatment of Concanavalin A-Induced Acute Liver Injury of BALB/c Mice

Correction to “Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment”

Correction to Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1h,3h,5h)-trione Derivatives for the Treatment of Obesity-Related Nonalcoholic Fatty Liver Disease

Correction to Metabolomic and Genomic Evidence for Compromised Bile Acid Homeostasis by Senecionine, a Hepatotoxic Pyrrolizidine Alkaloid

Correction: Corrigendum: Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury

Correction to Evaluation and Discovery of Novel Synthetic Chalcone Derivatives As Anti-Inflammatory Agents

Correction to Acenaphtho[1,2-b]pyrrole-Based Selective Fibroblast Growth Factor Receptors 1 (FGFR1) Inhibitors: Design, Synthesis, and Biological Activity

Corrigendum: Adiponectin-derived Active Peptide ADP355 Exerts Anti-Inflammatory and Anti-Fibrotic Activities in Thioacetamide-Induced Liver Injury.

Correction to Synthetic Approaches to the New Drugs Approved During 2015

Correction to N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent

Correction to Bioactive Indole Alkaloids and Phenyl Ether Derivatives from a Marine-Derived Aspergillus Sp. Fungus

Correction to “hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice”

Synthesis and Biological Evaluation of Novel Dimethyl[1,1 '-Biphenyl]-2,2 '-Dicarboxylate Derivatives Containing Thiazolidine-2,4-Dione for the Treatment of Concanavalin A-Induced Acute Liver Injury of Balb/C Mice

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor

Correction to Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection

Correction to Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

(Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, A Novel Readily Available and Orally Active Glitazone, Attenuates the Bleomycin-Induced Pulmonary Fibrosis in Vivo

Correction to “ultrasmall RuO2 Nanozyme Exhibiting Multienzyme-like Activity for the Prevention of Acute Kidney Injury”

Correction to “BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo”

Correction: Tacrolimus (FK506) Prevents Early Stages of Ethanol Induced Hepatic Fibrosis by Targeting LARP6 Dependent Mechanism of Collagen Synthesis